eyeFusion for Blind Spot

Phase-Based Progress Estimates
University of Iowa, Iowa City, IABlind SpoteyeFusion - Device
18 - 80
All Sexes
What conditions do you have?

Study Summary

This trial is testing an app that could be used to quickly and easily measure a patient's flicker fusion frequency, which is important for diagnosing optic disorders.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: 1/1/2020

Assess Validity of the test construct measuring flicker fusion thresholds.

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

eyeFusion Control Subjects
1 of 2
eyeFusion Patients
1 of 2

Active Control

Experimental Treatment

500 Total Participants · 2 Treatment Groups

Primary Treatment: eyeFusion · No Placebo Group · N/A

eyeFusion Patients
Experimental Group · 1 Intervention: eyeFusion · Intervention Types: Device
eyeFusion Control Subjects
ActiveComparator Group · 1 Intervention: eyeFusion · Intervention Types: Device

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 1/1/2020

Who is running the clinical trial?

Randy KardonLead Sponsor
2 Previous Clinical Trials
620 Total Patients Enrolled
Randy Kardon, MD, PhDPrincipal Investigator - University of Iowa
Iowa City VA Medical Center, University of Iowa Chemical Dependency Center, University of Iowa Hospitals & Clinics
University Of Iowa College Of Medicine (Medical School)
University Iowa Hosps & Clinics (Residency)

Eligibility Criteria

Age 18 - 80 · All Participants · 5 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have a blind spot in your vision that is related to a medical condition.
This term is not specific enough to be summarized. Can you please provide more context or information?

Frequently Asked Questions

How many individuals have been invited to join this clinical trial?

"Confirmative, the particulars of this trial on clinicaltrials.gov indicate that it is currently accepting candidates. This research was initially launched on January 27th 2017 and edited most recently in July 4th 2022. The study requires 500 participants to enroll from 1 distinct medical facility." - Anonymous Online Contributor

Unverified Answer

Is this research open to individuals who are over four decades old?

"Researchers have identified that the acceptable age range for this clinical trial to be 18 - 80 years old." - Anonymous Online Contributor

Unverified Answer

To whom is participation in this trial available?

"Patients with scotoma, aged between 18 and 80 years old, are eligible to be enrolled in this medical experiment. The trial seeks 500 participants in total." - Anonymous Online Contributor

Unverified Answer

Is this trial still recruiting participants?

"Affirmative. According to information gathered from clinicaltrials.gov, this experiment was initially posted on January 27th 2017 and has been actively recruiting since then. The study is in search of 500 participants at one medical centre." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.